Agency Information Collection Activities: Submission for OMB Review; Comment Request, 76292-76293 [2015-30892]
Download as PDF
<![CDATA[
76292
Federal Register / Vol. 80, No. 235 / Tuesday, December 8, 2015 / Notices
previous year to determine whether the
results consistent. In addition to
comparing the unweighted and
weighted frequencies, the input and
output specifications are reviewed, and
the flowcharts are compared to the skip
instructions and universes for each
question. If a difference is found, steps
are taken to determine whether the
change is legitimate or whether there is
a factor other than the programming of
the questionnaire such as the location or
context of the question in the
questionnaire. If a difference persists,
the paradata are reviewed to determine
whether there are changes in the mean
or median time spent on that question,
whether interviewers had a high rate of
backing up to return to that question,
and whether other questions in that
battery were similarly affected.
Persistent differences will be examined
to determine whether there is any other
interviewer effect such as results
comparing newly hired and experienced
interviewers and newly added primary
sampling units compared to continuing
primary sampling units. In addition,
national estimates on the key set of
indicators that are released in a
quarterly report as part of the Early
Release program will be monitored by
NHIS analysts.
In accordance with the 1995 initiative
to increase the integration of surveys
within the DHHS, respondents to the
NHIS serve as the sampling frame for
the Medical Expenditure Panel Survey
conducted by the Agency for Healthcare
Research and Quality. The NHIS has
long been used by government,
academic, and private researchers to
evaluate both general health and
specific issues, such as smoking,
diabetes, health care coverage, and
access to health care. It is a leading
source of data for the Congressionallymandated ‘‘Health US’’ and related
publications, as well as the single most
important source of statistics to track
progress toward the National Health
Promotion and Disease Prevention
Objectives, ‘‘Healthy People 2020.’’
Burden hours have seen a net increase
of 1,367 hours compared to 2015 due to
the removal of the screener
questionnaire and the addition of the
questionnaire redesign activities. There
is no cost to the respondents other than
their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Type of respondents
Form name
Adult Family Member ......................................
Sample Adult ...................................................
Adult Family Member ......................................
Adult Family Member ......................................
Adult Family Member ......................................
Adult Family Member ......................................
Family Questionnaire .....................................
Sample Adult Questionnaire ..........................
Sample Child Questionnaire ..........................
Supplements ..................................................
Special Projects .............................................
Reinterview Questions ...................................
45,000
36,000
14,000
45,000
15,000
5,000
1
1
1
1
1
1
23/60
15/60
10/60
20/60
20/60
5/60
Total .........................................................
.........................................................................
........................
........................
49,000
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–30854 Filed 12–7–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10583]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
Lhorne on DSK9F6TC42PROD with NOTICES
SUMMARY:
14:17 Dec 07, 2015
Comments on the collection(s) of
information must be received by the
OMB desk officer by January 7, 2016:
DATES:
Notice.
VerDate Sep<11>2014
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Jkt 238001
When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
ADDRESSES:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
SUPPLEMENTARY INFORMATION:
E:\FR\FM\08DEN1.SGM
08DEN1
Lhorne on DSK9F6TC42PROD with NOTICES
Federal Register / Vol. 80, No. 235 / Tuesday, December 8, 2015 / Notices
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Data Collection
for Medicare Beneficiaries Receiving
Beta Amyloid Positron Emission
Tomography (PET) for Dementia and
Neurodegenerative Disease Use: In the
Decision Memorandum #CAG–00431N
issued on September 27, 2013, CMS
determined there is sufficient evidence
that the use of beta amyloid PET is
promising in 2 scenarios: (1) To exclude
Alzheimer’s Disease (AD) in narrowly
defined and clinically difficult
differential diagnoses; and (2) to enrich
clinical trials seeking better treatments
or prevention strategies for AD. CMS
will cover one beta amyloid PET scan
per patient through Coverage with
Evidence Development under section
1862(a)(1)(E) of the Social Security Act,
in clinical studies that meet specific
criteria established by CMS. Clinical
studies must be approved by CMS,
involve subjects from appropriate
populations, and be comparative and
longitudinal. Radiopharmaceuticals
used in the scan must be FDA approved.
Approved studies must address defined
research questions established by CMS.
Clinical studies in this National
Coverage Determination (NCD) must
adhere to the designated timeframe and
meet standards establish by CMS in the
NCD. Consistent with section 1142 of
the Social Security Act, the Agency for
Healthcare and Quality (AHRQ)
supports clinical research studies that
CMS determines meet specifically
identified requirements and research
questions.
To qualify for payment, providers
must prescribe beta amyloid PET for
beneficiaries with a set of clinical
criteria specific to each cancer. Data
elements will be transmitted to CMS for
evaluation of the short and long-term
benefits of beta amyloid PET to
beneficiaries and for use in future
clinical decision making. Form Number:
CMS–10583 (OMB control number:
0938–NEW); Frequency: Annually;
Affected Public: Private sector (Business
VerDate Sep<11>2014
14:17 Dec 07, 2015
Jkt 238001
or other for-profit); Number of
Respondents: 300; Total Annual
Responses: 3,700; Total Annual Hours:
6,475. (For policy questions regarding
this collection contact Stuart Caplan at
410–786–8564).
Dated: December 3, 2015.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2015–30892 Filed 12–7–15; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–R–193 and
CMS–R–244]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments must be received by
February 8, 2016.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
DATES:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
76293
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–R–193 Important Message from
Medicare (IM)
CMS–R–244 Programs for Allinclusive Care of the Elderly (PACE)
and Supporting Regulations
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
E:\FR\FM\08DEN1.SGM
08DEN1
]]>Agencies
[Federal Register Volume 80, Number 235 (Tuesday, December 8, 2015)]
[Notices]
[Pages 76292-76293]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30892]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10583]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by January 7, 2016:
ADDRESSES: When commenting on the proposed information collections,
please reference the document identifier or OMB control number. To be
assured consideration, comments and recommendations must be received by
the OMB desk officer via one of the following transmissions: OMB,
Office of Information and Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395-5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786-
1326.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
[[Page 76293]]
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection: Data
Collection for Medicare Beneficiaries Receiving Beta Amyloid Positron
Emission Tomography (PET) for Dementia and Neurodegenerative Disease
Use: In the Decision Memorandum #CAG-00431N issued on September 27,
2013, CMS determined there is sufficient evidence that the use of beta
amyloid PET is promising in 2 scenarios: (1) To exclude Alzheimer's
Disease (AD) in narrowly defined and clinically difficult differential
diagnoses; and (2) to enrich clinical trials seeking better treatments
or prevention strategies for AD. CMS will cover one beta amyloid PET
scan per patient through Coverage with Evidence Development under
section 1862(a)(1)(E) of the Social Security Act, in clinical studies
that meet specific criteria established by CMS. Clinical studies must
be approved by CMS, involve subjects from appropriate populations, and
be comparative and longitudinal. Radiopharmaceuticals used in the scan
must be FDA approved. Approved studies must address defined research
questions established by CMS. Clinical studies in this National
Coverage Determination (NCD) must adhere to the designated timeframe
and meet standards establish by CMS in the NCD. Consistent with section
1142 of the Social Security Act, the Agency for Healthcare and Quality
(AHRQ) supports clinical research studies that CMS determines meet
specifically identified requirements and research questions.
To qualify for payment, providers must prescribe beta amyloid PET
for beneficiaries with a set of clinical criteria specific to each
cancer. Data elements will be transmitted to CMS for evaluation of the
short and long-term benefits of beta amyloid PET to beneficiaries and
for use in future clinical decision making. Form Number: CMS-10583 (OMB
control number: 0938-NEW); Frequency: Annually; Affected Public:
Private sector (Business or other for-profit); Number of Respondents:
300; Total Annual Responses: 3,700; Total Annual Hours: 6,475. (For
policy questions regarding this collection contact Stuart Caplan at
410-786-8564).
Dated: December 3, 2015.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2015-30892 Filed 12-7-15; 8:45 am]
BILLING CODE 4120-01-P
